Pricing Log in Create free account

4D Molecular Therapeutics, Inc. (FDMT) vs Sagimet Biosciences Inc. (SGMT)

4D Molecular Therapeutics, Inc. and Sagimet Biosciences Inc. are both Biotechnology companies. 4D Molecular Therapeutics, Inc. and Sagimet Biosciences Inc. are of similar size ($641.5M and $621.5M). Sagimet Biosciences Inc. has the higher net margin (0.00% vs −194.7%) and the lower return on invested capital (−205.2% vs −186.9%). Across the 14 metrics below, Sagimet Biosciences Inc. leads on 11 and 4D Molecular Therapeutics, Inc. on 3.

Valuation

Metric FDMT SGMT Biotechnology median
P/E n/m n/m 10.60
P/S 9.41 n/m 9.40
P/B 2.12 2.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 5.70 n/m 9.02
Earnings yield (22.38%) (13.03%) (32.88%)
Free cash flow yield (18.01%) (8.00%) (23.13%)

Profitability

Metric FDMT SGMT Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (214.24%) 0.00% 0.00%
Net margin (194.74%) 0.00% 0.00%
Free cash flow margin (169.51%) 0.00% 0.00%
Return on equity (43.25%) (24.37%) (51.96%)
Return on assets (37.09%) (23.49%) (46.06%)
Return on invested capital (186.91%) (205.24%) 0.00%

Growth

Metric FDMT SGMT Biotechnology median
Revenue growth (TTM) 278,712.12% — 6.76%
EPS growth (last fiscal year) 18.79% (8.97%) 29.88%
Revenue growth, 5-year CAGR 44.32% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FDMT SGMT Biotechnology median
Debt to equity 0.05 0.00 0.00
Current ratio 8.03 45.02 4.97
Net debt to EBITDA 2.52 1.98 1.01

Dividend

Metric FDMT SGMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FDMT SGMT Biotechnology median
Market cap 621.50m 641.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack